Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01632969 · ClinicalTrials.gov registry record
Improving End of Life Care in Head and Neck Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Terminated
- Registry status
- 2
- Enrollment target
NCT01632969: Clinical Trial study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01632969 is a clinical trial that was terminated before completion, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01632969 was terminated before completion, sponsored by Memorial Sloan Kettering Cancer Center.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to improve the quality of care provided for head and neck cancer patients. By better understanding the end of life experiences of dying patients and their families, the investigators hope to better anticipate and improve upon the experiences of future patients and their families.
Interventions
- BEHAVIORAL The The Family Assessment of Treatment at the End of life (FATE ) survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01632969
The ClinicalTrials.gov registry entry for NCT01632969 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which The The Family Assessment of Treatment at the End of life (FATE ) survey is the first listed.
NCT01632969 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01632969 about?
NCT01632969 is a clinical study titled "Improving End of Life Care in Head and Neck Cancer". The purpose of this study is to improve the quality of care provided for head and neck cancer patients. By better understanding the end of life experiences of dying patients and their families, the investigators hope to better anticipate and improve upon the experiences of future patients and their ...
What is the current status of trial NCT01632969?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2012-06. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01632969?
The interventions under investigation include: The The Family Assessment of Treatment at the End of life (FATE ) survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT01632969?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.